B19 parvovirus and blood transfusion

Area of Science:

• Virology
• Hematology
• Immunology

Background:

• Parvovirus B19 is a small, non-enveloped DNA virus.
• It typically causes mild illness like fifth disease in children and arthritis in adults.
• The virus targets erythroid progenitor cells, essential for red blood cell production.

Purpose of the Study:

• To investigate the potential for Parvovirus B19 to cause anemia.
• To explore the circumstances under which Parvovirus B19-induced anemia may occur in blood transfusion recipients.
• To understand the clinical manifestations of Parvovirus B19 infection in specific patient populations.

Main Methods:

• Review of clinical cases and transfusion histories.
• Serological testing for Parvovirus B19 infection.
• Analysis of hematological parameters in affected patients.

Main Results:

• Parvovirus B19 infection can lead to acute or chronic anemia.
• Anemia occurs due to the lysis of erythroid progenitor cells by the virus.
• These hematological complications are particularly relevant in blood-transfused individuals.

Conclusions:

• Parvovirus B19 poses a risk for causing anemia, especially in immunocompromised or transfused patients.
• Understanding the pathogenesis is crucial for managing Parvovirus B19-related hematological disorders.
• Further studies are needed to define the specific risk factors and management strategies.